SI-BONE, Inc. (SIBN) Key Metrics
SIBN valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $872.8M
- Enterprise value
- $731.4M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 4.1 10-yr median 5.9
- Price / book
- 4.6 10-yr median 4.8
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.66
SIBN key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsSIBN valuation Price multiples at each fiscal year-end price.
Price / sales+22.8%
4.3
2025 · hover or tap a bar for each year
20162025
Price / book+38.8%
4.8
2025 · hover or tap a bar for each year
20162025
Free cash flow yield+2.9 pts
−1.1%
2025 · hover or tap a bar for each year
20162025
SIBN returns How much profit the business earns on the capital it uses.
Return on equity+7.4 pts
−11.0%
2025 · hover or tap a bar for each year
20162025
Return on invested capital+16.2 pts
−41.4%
2025 · hover or tap a bar for each year
20162025
Return on assets+5.4 pts
−8.1%
2025 · hover or tap a bar for each year
20162025
Free cash flow margin+9.2 pts
−4.5%
2025 · hover or tap a bar for each year
20162025
Asset turnover+18.1%
0.86
2025 · hover or tap a bar for each year
20162025
SIBN per-share figures Results divided by the shares outstanding at year-end.
Revenue per share+14.5%
$4.62
2025 · hover or tap a bar for each year
20162025
Earnings per share
−$0.43
2025 · hover or tap a bar for each year
20162025
Free cash flow per share
−$0.21
2025 · hover or tap a bar for each year
20162025
Book value per share+1.3%
$4.08
2025 · hover or tap a bar for each year
20162025
Shares outstanding+4.9%
43.5M
2025 · hover or tap a bar for each year
20162025
SIBN financial health Debt, liquidity and how easily interest is covered.
Debt / equity−97.2%
0.01
2025 · hover or tap a bar for each year
20162025
Net debt−$34.1M
−$146.7M
2025 · hover or tap a bar for each year
20162025
Current ratio+11.6%
8.55
2025 · hover or tap a bar for each year
20162025
Interest coverage
-4.2
2025 · hover or tap a bar for each year
20162025
Debt / assets−97.1%
0.00
2025 · hover or tap a bar for each year
20162025
SIBN efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding−2 days
52 days
2025 · hover or tap a bar for each year
20162025
Days of inventory+25 days
271 days
2025 · hover or tap a bar for each year
20162025
Days payables outstanding−8 days
49 days
2025 · hover or tap a bar for each year
20162025
Cash conversion cycle+31 days
274 days
2025 · hover or tap a bar for each year
20162025
Capex / revenue−2.1 pts
4.2%
2025 · hover or tap a bar for each year
20162025
SIBN valuation history
Fiscal year-endToday10-year median
SIBN returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
SIBN debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
SIBN cash returned to shareholders
DividendsBuybacksFree cash flow
SIBN price vs earnings per share
Share price at year-endEPS (right axis)
SIBN key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $858.0M | $581.4M | $806.6M | $465.1M | $736.2M | $868.9M | $531.2M | $332.2M | — | — |
| Enterprise value | $711.3M | $468.8M | $679.6M | $407.3M | $629.7M | $711.9M | $478.6M | $248.9M | — | — |
| Price / sales | 4.3 | 3.5 | 5.8 | 4.4 | 8.2 | 11.8 | 7.9 | 6.0 | — | — |
| Price / book | 4.8 | 3.5 | 4.8 | 4.7 | 5.5 | 5.1 | 8.4 | 3.7 | — | — |
| EV / sales | 3.5 | 2.8 | 4.9 | 3.8 | 7.0 | 9.7 | 7.1 | 4.5 | — | — |
| Earnings yield | −2.2% | −5.3% | −5.4% | −13.2% | −7.7% | −5.0% | −7.2% | −5.3% | — | — |
| Free cash flow yield | −1.1% | −3.9% | −3.3% | −11.0% | −6.2% | −3.8% | −6.4% | −4.7% | — | — |
| Dividend yield | — | — | 0.3% | — | 0.7% | 0.2% | — | — | — | — |
| Shareholder yield (dividends + buybacks) | 0.0% | 0.0% | 0.3% | 0.0% | 0.7% | 0.2% | 0.0% | 0.0% | — | — |
| Share price at fiscal year-end | $19.72 | $14.02 | $20.99 | $13.60 | $22.21 | $29.90 | $21.50 | $20.89 | — | — |
| Per share | ||||||||||
| Revenue per share | $4.62 | $4.03 | $3.61 | $3.11 | $2.72 | $2.53 | $2.72 | $3.48 | $3.46 | $2.72 |
| Earnings per share | −$0.43 | −$0.75 | −$1.13 | −$1.79 | −$1.71 | −$1.50 | −$1.55 | −$1.10 | −$1.66 | −$1.33 |
| Operating cash flow per share | −$0.02 | −$0.30 | −$0.49 | −$1.22 | −$1.19 | −$1.06 | −$1.28 | −$0.91 | −$1.26 | −$1.08 |
| Free cash flow per share | −$0.21 | −$0.55 | −$0.69 | −$1.50 | −$1.39 | −$1.14 | −$1.38 | −$0.97 | −$1.30 | −$1.11 |
| Cash per share | $3.40 | $3.62 | $4.32 | $2.84 | $4.43 | $6.76 | $3.71 | $7.69 | $1.62 | $1.80 |
| Book value per share | $4.08 | $4.03 | $4.41 | $2.87 | $4.06 | $5.83 | $2.55 | $5.67 | −$9.33 | −$7.02 |
| Tangible book value per share | $4.08 | $4.03 | $4.41 | $2.87 | $4.06 | $5.83 | $2.55 | $5.67 | −$9.33 | −$7.03 |
| Dividends per share | — | — | $0.06 | — | $0.15 | $0.07 | — | — | — | — |
| Capex per share | $0.19 | $0.25 | $0.20 | $0.28 | $0.19 | $0.09 | $0.10 | $0.06 | $0.03 | $0.03 |
| Debt per share | $0.03 | $0.90 | $1.01 | $1.15 | $1.22 | $1.36 | $1.59 | $2.45 | $5.61 | $1.93 |
| Shares outstanding | 43.5M | 41.5M | 38.4M | 34.2M | 33.1M | 29.1M | 24.7M | 15.9M | 13.9M | 15.5M |
| Change in shares outstanding | +4.9% | +7.9% | +12.4% | +3.2% | +14.1% | +17.6% | +55.4% | +14.7% | −10.4% | −35.7% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −11.0% | −18.4% | −32.4% | −52.6% | −37.2% | −37.6% | −50.1% | — | — | — |
| Return on invested capital (ROIC) | −41.4% | −57.6% | −89.6% | −137.8% | −202.6% | −266.8% | −327.2% | — | — | — |
| Return on assets (ROA) | −8.1% | −13.4% | −22.3% | −35.2% | −27.4% | −25.7% | −30.1% | −20.0% | −61.2% | −54.5% |
| Return on tangible assets | −7.9% | −13.4% | −18.8% | −38.9% | −29.7% | −19.6% | −32.8% | −12.6% | −64.4% | −52.3% |
| Free cash flow margin | −4.5% | −13.7% | −19.1% | −48.1% | −50.9% | −45.3% | −50.6% | −27.9% | −37.5% | −40.8% |
| Financial health | ||||||||||
| Total debt | $1.1M | $37.5M | $39.0M | $39.4M | $40.5M | $39.5M | $39.2M | $39.0M | $77.8M | $29.9M |
| Cash & short-term investments | $147.8M | $150.0M | $166.0M | $97.3M | $147.0M | $196.4M | $91.8M | $122.2M | $22.4M | $27.9M |
| Net debt | −$146.7M | −$112.6M | −$127.0M | −$57.9M | −$106.5M | −$157.0M | −$52.6M | −$83.3M | $55.4M | $2.0M |
| Debt / equity | 0.01 | 0.22 | 0.23 | 0.40 | 0.30 | 0.23 | 0.62 | 0.43 | — | — |
| Debt / assets | 0.00 | 0.16 | 0.17 | 0.25 | 0.21 | 0.18 | 0.34 | 0.28 | 2.17 | 0.76 |
| Current ratio | 8.55 | 7.66 | 9.01 | 6.50 | 10.41 | 16.20 | 5.94 | 15.11 | 4.46 | 2.71 |
| Quick ratio | 7.21 | 6.66 | 8.15 | 5.68 | 9.73 | 15.78 | 5.65 | 14.73 | 4.12 | 2.60 |
| Interest coverage | -4.2 | -10.2 | -13.6 | -21.1 | -9.6 | -6.3 | -7.3 | -2.2 | -2.8 | -5.3 |
| Working capital | $190.8M | $180.6M | $187.9M | $116.4M | $159.0M | $204.8M | $92.7M | $127.0M | $26.1M | $22.9M |
| Invested capital | $30.8M | $54.4M | $42.3M | $40.4M | $27.9M | $12.4M | $10.5M | $6.9M | −$74.0M | −$106.7M |
| Tangible asset value | $177.5M | $167.0M | $169.4M | $98.3M | $134.4M | $169.4M | $63.0M | $90.2M | −$129.4M | −$108.8M |
| Net current asset value | $155.1M | $144.3M | $150.3M | $78.4M | $119.8M | $164.5M | $57.5M | $87.7M | −$131.6M | −$111.8M |
| Graham net-net per share | $2.90 | $2.91 | $3.42 | $1.82 | $3.24 | $5.36 | $2.00 | $5.15 | −$9.80 | −$7.43 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | $2.2M | — | $4.9M | $1.9M | — | — | — | — |
| Share buybacks (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $73,000 | $0 | $3,000 |
| Capex / revenue | 4.2% | 6.3% | 5.6% | 8.9% | 7.1% | 3.5% | 3.6% | 1.7% | 1.0% | 1.0% |
| Capex / depreciation | 3.09 | 2.40 | 1.44 | 2.75 | 3.06 | 2.27 | 3.16 | 1.30 | 0.47 | 0.42 |
| Stock-based compensation / revenue | 12.7% | 15.5% | 17.3% | 21.7% | 18.7% | 16.3% | 11.1% | 4.2% | 3.0% | 3.3% |
| R&D / revenue | 8.7% | 9.9% | 10.8% | 12.8% | 13.8% | 12.9% | 10.8% | 9.7% | 11.5% | 15.2% |
| SG&A / revenue | 82.0% | 90.2% | 101.8% | 128.5% | 131.9% | 127.5% | 132.6% | 103.2% | 114.0% | 114.3% |
| Efficiency | ||||||||||
| Days sales outstanding | 52.1 | 53.9 | 56.0 | 59.9 | 56.4 | 63.0 | 54.8 | 52.4 | 50.8 | 50.8 |
| Days of inventory on hand | 271.1 | 246.4 | 232.5 | 334.4 | 299.8 | 227.3 | 236.4 | 222.6 | 145.2 | 148.9 |
| Days payables outstanding | 49.4 | 57.7 | 67.3 | 110.1 | 113.2 | 124.7 | 133.2 | 149.5 | 101.4 | 124.3 |
| Cash conversion cycle (days) | 273.8 | 242.6 | 221.2 | 284.2 | 243.0 | 165.6 | 157.9 | 125.5 | 94.7 | 75.4 |
| Receivables turnover | 7.00 | 6.77 | 6.52 | 6.09 | 6.47 | 5.79 | 6.66 | 6.97 | 7.18 | 7.18 |
| Payables turnover | 7.38 | 6.33 | 5.42 | 3.31 | 3.22 | 2.93 | 2.74 | 2.44 | 3.60 | 2.94 |
| Inventory turnover | 1.35 | 1.48 | 1.57 | 1.09 | 1.22 | 1.61 | 1.54 | 1.64 | 2.51 | 2.45 |
| Asset turnover | 0.86 | 0.73 | 0.72 | 0.61 | 0.44 | 0.43 | 0.53 | 0.64 | 1.27 | 1.12 |
| Average receivables | $28.7M | $24.7M | $21.3M | $17.5M | $13.9M | $12.7M | $10.1M | $8.0M | $6.7M | $5.9M |
| Average payables | $5.6M | $5.5M | $5.4M | $4.7M | $3.2M | $3.0M | $2.5M | $2.0M | $1.4M | $1.8M |
| Average inventory | $30.5M | $23.7M | $18.8M | $14.4M | $8.6M | $5.5M | $4.4M | $2.9M | $2.0M | $2.1M |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% |
Computed from SIBN's annual financial statements (latest annual report filed February 24, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
SIBN valuation and financial ratios
SI-BONE earned a return on equity of −11.0% and a return on invested capital of −41.4% in fiscal 2025. It ended the year with $1.1 million of debt and $147.8 million in cash and short-term investments, a net cash position of $146.7 million. The share count rose 181.1% from 15.5M to 43.5M over 9 years.
See the SIBN income statement, the SIBN chart for price history, or the SIBN stock overview for the latest quote and news.
SIBN key metrics FAQ
What is SI-BONE's return on equity?
SI-BONE's return on equity (ROE) was −11.0% in fiscal 2025: net income of -$18.9 million on average shareholders' equity of $172.2 million.
What is SI-BONE's ROIC?
SI-BONE's return on invested capital was −41.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does SI-BONE have?
SI-BONE had total debt of $1.1 million at the end of fiscal 2025, a debt-to-equity ratio of 0.01 and more cash than debt.
What is SI-BONE's free cash flow yield?
SI-BONE generated -$9.1 million of free cash flow in fiscal 2025, a free cash flow yield of −1.1% on its market value at year-end ($858.0 million).
What is SI-BONE's current ratio?
SI-BONE's current ratio was 8.55 at the end of fiscal 2025: current assets were 8.55 times current liabilities.